[Etiology of cervical vaginal infection among patients of the Juárez Hospital of Mexico].

Salud Publica Mex

Hospital Juárez de México, Dirección de Investigación y Enseñanza, Avenida Instituto Politécnico Nacional No 5160, colonia Magdalena de las Salinas, 07760 México, DF.

Published: April 2004

Objective: To identify the etiologic agents of cervicovaginal infection in order to establish an accurate diagnosis and proper treatment.

Material And Methods: From January 1995 to December 1999, bacteriological studies were done in cervical discharge specimens from 6,811 patients aged 13 to 65 years, seen at Hospital Juarez in Mexico City. All patients had leucorrhea, pruritus, hyperemia, and abdominal pain. Statistical significance was assessed using the chi-squared test.

Results: The frequencies of infectious agents were as follows: G. vaginalis, 22.65%, Candida spp, 19.13%, C, albicans, 7.8%, T. vaginalis, 1.5%, Streptococcus group D, 11.78%, Streptococcus beta hemolytic, 4.59%, E. coli, 13.46%, and Klebsiella spp, 2.0%. Less frequent enterobacteria were: Citrobacter spp, Enterobacter spp, Pseudomonas spp, M. morganii, and P. mirabilis. Almost 3% of patients presented anaerobic species, which were always associated with G. vaginalis. Neisseria spp and N. weaveri were isolated in 0.15% each; N. gonorrhoeae was not isolated in any of the patients. Comparative data showed that Streptococcus beta hemolytic and E. coli increased markedly in the past two years (p < 0.001 for the latter).

Conclusions: The diversity of etiologic agents requires performing bacteriological cultures of cervical and vaginal discharge to all symptomatic patients. The English version of this paper is available at:http://www.insp.mx/salud/index.html.

Download full-text PDF

Source

Publication Analysis

Top Keywords

cervical vaginal
8
etiologic agents
8
streptococcus beta
8
beta hemolytic
8
patients
6
spp
6
[etiology cervical
4
vaginal infection
4
infection patients
4
patients juárez
4

Similar Publications

Introduction: Cervical dysplasia is a precursor lesion of cervical cancer, one of the leading causes of morbidity and mortality in women, especially in developing countries. This study aimed to identify the risk factors associated with the development of cervical dysplasia in women treated at the Santa María del Socorro Hospital in Ica, Peru, between 2017 and 2019.

Methods: An observational case-control study was conducted with 92 cases of women with confirmed high-grade intraepithelial lesion and 184 controls with consecutive negative results in Pap smears.

View Article and Find Full Text PDF

Human papillomavirus (HPV) is a key factor in gynecological oncology. This narrative review investigates the complex connection between HPV and various gynecological cancers. For a comprehensive exploration, we examined the association between persistent HPV infection and cervical cancer and its global prevalence.

View Article and Find Full Text PDF

Purpose: To compare the clinical outcomes of two different schedules of modern image-guided adaptive brachytherapy (IGABT) in patients underwent chemoradiotherapy (CCRT) and high-dose rate (HDR) brachytherapy (BT) for locally advanced cervical cancer treated (LACC) METHODS AND MATERIALS: Data from medical records of all consecutive patients with histologically proven cervical cancer (FIGO 2018 stage IB-IVA) treated by HDR-BT after CCRT at our institution between 2016 and 2021 were reviewed.

Results: Two hundred and 8 patients with LACC FIGO 2018 stages (IB 20.7%; II 26.

View Article and Find Full Text PDF

Clinical Benefit of a Conservative Treatment for High-Risk Human Papillomavirus Lesions in Patients with HIV.

AIDS Res Hum Retroviruses

January 2025

Servicio de Ginecología y Obstetricia, Hospital Universitario Torrecárdenas, GAEPI-VPH (Grupo Andaluz para el Estudio y la Prevención de la Infección por VPH), Almería, Spain.

Infection with Human immunodeficiency virus (HIV) shows a higher risk of infection by Human papillomavirus (HPV). We aim to provide evidence about the effect of a -based vaginal gel (Papilocare®) for treating HPV in women with HIV. Women ≥25 years coinfected by endocervical HPV and with low-grade abnormal cervicovaginal cytology were treated for 6 months with Papilocare® in this observational, prospective, non-controlled pilot study.

View Article and Find Full Text PDF

This systematic review and meta-analysis evaluate human papillomavirus (HPV) prevalence, genotype distribution, and associations with cervicovaginal microbiota and cytokine profiles among South African women, where cervical cancer ranks as the second most common cancer. PubMed, SCOPUS, and Web of Science were searched for studies on HPV infection up to 21 September 2024. The pooled prevalence was estimated using a random-effects model, with subgroup analyses by province, sample type, and HIV status.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!